These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28024842)

  • 1. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.
    Aharoni S; Sadeh M; Shapira Y; Edvardson S; Daana M; Dor-Wollman T; Mimouni-Bloch A; Halevy A; Cohen R; Sagie L; Argov Z; Rabie M; Spiegel R; Chervinsky I; Orenstein N; Engel AG; Nevo Y
    Neuromuscul Disord; 2017 Feb; 27(2):136-140. PubMed ID: 28024842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital Myasthenic Syndrome: Spectrum of Mutations in an Indian Cohort.
    Selvam P; Arunachal G; Danda S; Chapla A; Sivadasan A; Alexander M; Thomas MM; Thomas NJ
    J Clin Neuromuscul Dis; 2018 Sep; 20(1):14-27. PubMed ID: 30124556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of congenital myasthenic syndromes in Spain.
    Natera-de Benito D; Töpf A; Vilchez JJ; González-Quereda L; Domínguez-Carral J; Díaz-Manera J; Ortez C; Bestué M; Gallano P; Dusl M; Abicht A; Müller JS; Senderek J; García-Ribes A; Muelas N; Evangelista T; Azuma Y; McMacken G; Paipa Merchan A; Rodríguez Cruz PM; Camacho A; Jiménez E; Miranda-Herrero MC; Santana-Artiles A; García-Campos O; Dominguez-Rubio R; Olivé M; Colomer J; Beeson D; Lochmüller H; Nascimento A
    Neuromuscul Disord; 2017 Dec; 27(12):1087-1098. PubMed ID: 29054425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum.
    Hesami O; Ramezani M; Ghasemi A; Fatehi F; Okhovat AA; Ziaadini B; Kariminejad A; Nafissi S
    Orphanet J Rare Dis; 2024 Mar; 19(1):113. PubMed ID: 38475910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
    Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
    Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First characterization of congenital myasthenic syndrome type 5 in North Africa.
    Khaoula R; Cerino M; Da Silva N; Delague V; Nahili H; Kriouile Y; Gorokhova S; Bartoli M; Saïle R; Barakat A; Krahn M
    Mol Biol Rep; 2021 Oct; 48(10):6999-7006. PubMed ID: 34553317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
    Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
    Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.
    Mihaylova V; Scola RH; Gervini B; Lorenzoni PJ; Kay CK; Werneck LC; Stucka R; Guergueltcheva V; von der Hagen M; Huebner A; Abicht A; Müller JS; Lochmüller H
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):973-7. PubMed ID: 20562457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by
    Shao S; Shi G; Bi FF; Huang K
    Curr Neuropharmacol; 2023; 21(7):1594-1605. PubMed ID: 36703579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital myasthenic syndromes in the Thai population: Clinical findings and novel mutations.
    Pattrakornkul N; Ittiwut C; Boonsimma P; Boonyapisit K; Khongkhatithum C; Sanmaneechai O; Suphapeetiporn K; Shotelersuk V
    Neuromuscul Disord; 2020 Oct; 30(10):851-858. PubMed ID: 32978031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent COLQ mutation in congenital myasthenic syndrome.
    Guven A; Demirci M; Anlar B
    Pediatr Neurol; 2012 Apr; 46(4):253-6. PubMed ID: 22490774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.
    Ohno K; Sadeh M; Blatt I; Brengman JM; Engel AG
    Hum Mol Genet; 2003 Apr; 12(7):739-48. PubMed ID: 12651869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
    Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
    FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein.
    Laforgia N; De Cosmo L; Palumbo O; Ranieri C; Sesta M; Capodiferro D; Pantaleo A; Iapicca P; Lastella P; Capozza M; Schettini F; Bukvic N; Bagnulo R; Resta N
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33353066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital myasthenic syndrome: a brief review.
    Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
    Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
    Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
    Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
    Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.